Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives
P Vernia, V D'Ovidio, D Meo - Transfusion and Apheresis Science, 2010 - Elsevier
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …
decade for the treatment of ulcerative colitis with promising result, and represents an …
Cytapheresis in inflammatory bowel diseases: current evidence and perspectives
S Danese, E Angelucci, T Stefanelli, P Omodei… - Digestion, 2008 - karger.com
Ulcerative colitis and Crohn's disease are inflammatory bowel diseases with a chronic
relapsing course. Management of both conditions is far from being fully satisfactory. For this …
relapsing course. Management of both conditions is far from being fully satisfactory. For this …
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action
K Mitsuyama, M Sata - Cytotherapy, 2009 - Elsevier
Intense infiltration of the intestinal mucosa by activated leukocytes is a hallmark of
inflammatory bowel disease (IBD). Therefore, removal of circulating leukocytes may be an …
inflammatory bowel disease (IBD). Therefore, removal of circulating leukocytes may be an …
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia
T Ljung, O Østergaard Thomsen, M Vatn… - Scandinavian journal …, 2007 - Taylor & Francis
Objective. Selective leukocyte apheresis is a new type of non-pharmacological treatment for
patients with active ulcerative colitis and Crohn's disease. Preliminary data have indicated …
patients with active ulcerative colitis and Crohn's disease. Preliminary data have indicated …
[HTML][HTML] Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis
H Hanai - World Journal of Gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Ulcerative colitis (UC) and Crohn's disease (CD) are the major forms of idiopathic
inflammatory bowel disease (IBD). Both UC and CD are debilitating chronic disorders that …
inflammatory bowel disease (IBD). Both UC and CD are debilitating chronic disorders that …
Leukocytapheresis as promising therapy for inflammatory bowel disease
R Caprilli, V D'Ovidio - Digestive and liver disease, 2007 - dldjournalonline.com
Leukocytapheresis, device used to remove leukocytes from peripheral circulation, has been
approved for the treatment of active ulcerative colitis (UC) by the Ministry of Health and …
approved for the treatment of active ulcerative colitis (UC) by the Ministry of Health and …
Granulocyte/monocyte apheresis as immunotherapic tool: cellular adsorption and immune modulation
E Cuadrado - Autoimmunity Reviews, 2009 - Elsevier
Cellular apheresis is now established as a rational therapeutic procedure in certain
inflammatory and autoimmune diseases, particularly in inflammatory bowel diseases, but the …
inflammatory and autoimmune diseases, particularly in inflammatory bowel diseases, but the …
Leucocytapheresis for ulcerative colitis
PM Irving, DS Rampton - Digestive and liver disease, 2004 - dldjournalonline.com
Reports describing the successful treatment of active, steroid-resistant inflammatory bowel
disease (IBD) with leucocytapheresis first emerged about 10 years ago. Since then, several …
disease (IBD) with leucocytapheresis first emerged about 10 years ago. Since then, several …
Developments in the apheresis procedure for the treatment of inflammatory bowel disease
AA Pineda - Inflammatory bowel diseases, 2006 - academic.oup.com
Initially used to treat rheumatoid arthritis, nonselective therapeutic leukocytapheresis was
applied to the treatment of inflammatory bowel disease (IBD) as early as the 1980s. Since …
applied to the treatment of inflammatory bowel disease (IBD) as early as the 1980s. Since …
[HTML][HTML] A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis
Y Suzuki, N Yoshimura, K Fukuda, K Shirai… - Digestive diseases and …, 2006 - Springer
Recently, selective granulocytapheresis (Adacolumn) has appeared as a new treatment for
patients with inflammatory bowel disease. This study sought to determine predictors of …
patients with inflammatory bowel disease. This study sought to determine predictors of …